bims-camemi Biomed News
on Mitochondrial metabolism in cancer
Issue of 2026–11–01
43 papers selected by
Christian Frezza, Universität zu Köln



  1. Nature. 2026 Oct 28.
      The heart possesses a dynamic capacity to oxidize a variety of fuels, including glucose and lactate, to meet its energetic demands under diverse dietary, exertion and injury stressors1. Oxidation of carbohydrate substrates is thought to converge on the cytosolic generation of pyruvate, which is transported by the mitochondrial pyruvate carrier (MPC) for entry into the tricarboxylic acid cycle2. Here we find that glucose-derived carbon is oxidized in mouse myocardium even when the MPC is genetically ablated. Using genetic and pharmacological tools, we demonstrate that lactate monocarboxylate transporter 1 (MCT1, encoded by Slc16a1) is required for the oxidation of glucose carbon by MPC-deficient myocardium. We further observe that MCT1, traditionally localized to the plasma membrane, also resides in the inner mitochondrial membrane of mouse and human cardiomyocytes. Together with matrix-localized LDHB, MCT1 enables mitochondrial lactate conversion to pyruvate and NADH, directly fueling the electron transport chain. Loss of MCT1 impairs lactate oxidation, disrupts metabolic flexibility and accelerates the development of heart failure with increased mortality after hyperactivation of the neurohormonal axis or ischemia-reperfusion injury. Thus, the existence of a parallel lactate-based pathway for carbohydrate oxidation can sustain cardiac energetics and maintain myocardial structure and function under diverse stress conditions.
    DOI:  https://doi.org/10.1038/s41586-026-11182-3
  2. Nat Metab. 2026 Oct 27.
      Mutations in mitochondrial DNA (mtDNA) impair ETC activity and oxidative phosphorylation, but their phenotypic consequences vary with heteroplasmy levels. Whether increasing mtDNA heteroplasmy creates metabolic dependencies not present in respiratory-competent cells remains unknown. Here, we show that low pyruvate carboxylase (PC) expression creates an asparagine dependency in high-mtDNA-heteroplasmy, respiration-compromised cells. In isogenic cells carrying similar mtDNA deletions, respiration declines linearly with increasing heteroplasmy, whereas redox imbalance emerges only above 50% heteroplasmy. Above 70% heteroplasmy, integrated stress-response-associated translational defects emerge, which can be reversed by either exogenous asparagine or PC overexpression. Asparagine dependence inversely correlates with PC expression across respiration-deficient cells. Consistent with this pattern, patient-derived thyroid tumour cells harbouring a high-heteroplasmy complex I mutation and low PC levels exhibit asparagine auxotrophy and sensitivity to L-asparaginase. Together, these findings demonstrate a role for mitochondrial PC in cellular asparagine synthesis under conditions of compromised respiratory activity.
    DOI:  https://doi.org/10.1038/s42255-026-01651-4
  3. Nat Cell Biol. 2026 Oct 28.
      Migrating cancer cells release diverse extracellular vesicles (EVs) that carry cargo capable of influencing tumour progression and intercellular communication. However, the mechanisms by which intracellular components are incorporated into EVs remain poorly understood. Here we identify and characterize a previously undescribed population of large EVs (2-5 μm), termed motile vesicles (MoVes), that are generated during active cancer cell migration and associated with epithelial-mesenchymal transition. Comparative analyses across EV populations show that MoVes display distinct ultrastructural features, molecular composition and sedimentation behaviour. Live-cell imaging and scanning electron microscopy reveal that MoVes arise from trailing-edge retraction during mesenchymal migration and are actively shed by cancer cells but rarely by non-transformed cells. MoVes contain genomic DNA spanning the genome of the parent cell, recapitulating its mutational landscape, as well as organelles and proteins associated with epithelial-mesenchymal transition. Moreover, MoVes-associated mitochondrial cargo can enhance oxidative phosphorylation in recipient cells. Together, these findings identify MoVes as a cancer cell migration-associated EV population capable of disseminating genomic DNA and organelles.
    DOI:  https://doi.org/10.1038/s41556-026-02097-2
  4. Sci Adv. 2026 Oct 30. 12(44): eaed1177
      Hypoxia-inducible factors (HIFs) are constitutively active in clear cell renal cell carcinoma (ccRCC) cells. Here, we investigated whether these cells could still respond to hypoxia independently of canonical HIF activation. We found that hypoxia provokes a NADH reductive stress that attenuates lactate release when the supply of extracellular pyruvate becomes limited, a response that was restored by the ectopic expression of the cytosolic and mitochondria-targeted NADH oxidase (LbNOX). Suppression of the mitochondrial electron transport chain (mtETC) alone is sufficient to attenuate glycolytic flux when extracellular pyruvate is limited, a situation consistent with metabolomic data from human ccRCCs. Furthermore, this response can be mimicked by pharmacological or genetic inhibition of mitochondrial complex IV (CIV) activity and restored by the mitochondrial-targeted alternative oxidase (AOX). Therefore, our data suggest that cells can respond to low oxygen tension through a mitochondrial-dependent elevation of NADH/NAD+, resulting in the suppression of glycolysis when pyruvate availability is compromised.
    DOI:  https://doi.org/10.1126/sciadv.aed1177
  5. bioRxiv. 2026 Oct 06. pii: 2026.10.01.756002. [Epub ahead of print]
      Tissue microenvironments differ widely in nutrient composition; yet how local nutrient conditions shape epigenetic programs that direct immune cell fate is poorly understood. We identify histone lysine propionylation (Kpr) as a chromatin mechanism linking nutrient availability to T cell fate decisions. Proteomic analysis reveals that Kpr is broadly reduced in exhausted T cells. H3K18pr is enriched at stemness-associated loci in effector T cells and depleted upon exhaustion. Isoleucine and propionate supply propionyl-CoA in T cells, and restricted nutrient availability within the tumor microenvironment limits histone Kpr, promoting T cell exhaustion. Disrupting isoleucine catabolism in T cells further suppresses Kpr, without altering histone acetylation, and impairs T cell function and antitumor immunity in a manner rescued by propionate. Dietary supplementation of isoleucine and propionate increases Kpr in tumor infiltrating lymphocytes, limits exhaustion, and improves tumor control. These findings establish a microenvironment-chromatin axis crucial for antitumor immunity and amenable to nutritional intervention.
    DOI:  https://doi.org/10.64898/2026.10.01.756002
  6. Trends Endocrinol Metab. 2026 Oct 27. pii: S1043-2760(26)00274-2. [Epub ahead of print]
      CD8+ T cells modulate their metabolism to support activation, proliferation, and effector function. The sulfur-containing amino acid cysteine is essential for these processes, but beyond its role in protein synthesis, cysteine is metabolized into multiple products that differentially regulate T cell immunity. Here, we review recent advances in understanding how intracellular cysteine routing controls CD8+ T cell function. Cysteine-derived glutathione, iron-sulfur clusters, coenzyme A, hydrogen sulfide, and taurine each have distinct effects on T cell activation, mitochondrial metabolism, and antitumor immunity. Additionally, cysteine-dependent post-translational modifications-including sulfenylation and persulfidation-modulate signaling and gene expression. Understanding how cells balance competing cysteine fates may reveal new therapeutic strategies to enhance T cell responses in cancer and other diseases.
    Keywords:  CD8(+) T cell; Fe–S cluster; cysteine; glutathione; immunometabolism; sulfur
    DOI:  https://doi.org/10.1016/j.tem.2026.10.002
  7. bioRxiv. 2026 Oct 09. pii: 2026.10.08.757432. [Epub ahead of print]
      In animals, the transition from egg to embryo marks a rapid shift in cellular physiology, yet how mitochondria adapt to support this conversion remains poorly understood. We performed a targeted RNAi screen of conserved, nuclear-encoded mitochondrial proteins in Drosophila melanogaster to identify maternal effects. We identified distinct phenotypic classes affecting mitochondrial distribution or morphology in early embryos. We focused on Sideroflexin-1/3 (Sfxn1-3), a conserved mitochondrial inner membrane transporter, because it uniquely affects embryonic mitochondrial morphology. Maternal loss of Sfxn1-3 causes striking mitochondrial enlargement in embryos but not in oocytes, placing the trigger at the egg-to-embryo transition. Combining mitochondrial immunopurification with LC/MS-based metabolomic profiling, we show that amino acids are markedly enriched in Sfxn1-3-deficient mitochondria in both oocytes and embryos. This accumulation developmentally uncouples the metabolic and morphological phenotypes. By selectively disrupting discrete steps of egg activation, including translational activation, cell cycle re-entry, and fertilization, we demonstrate that mitochondrial swelling is independent of each, prompted instead by egg hydration. Beyond its reported role in proliferating cells as a serine importer, our data support a role for germline Sfxn1-3 in regulating inner mitochondrial membrane permeability to osmotically active amino acids. This activity is crucial for preserving organelle volume during the osmotic challenge of oocyte hydration. When this export fails, amino acid accumulation amplifies osmotic stress and drives rapid mitochondrial swelling. Together, these findings identify mitochondrial inner membrane permeability to amino acids as a key regulatory step that couples pre-established metabolite compartmentalization to osmotic adaptation at egg activation, and reveal how mitochondrial metabolic integrity and volume control are coordinated at this critical developmental transition.
    DOI:  https://doi.org/10.64898/2026.10.08.757432
  8. Nature. 2026 Oct 28.
      
    Keywords:  Cell biology; Metabolism; Physiology
    DOI:  https://doi.org/10.1038/d41586-026-03261-2
  9. Cell Rep. 2026 Oct 26. pii: S2211-1247(26)01303-3. [Epub ahead of print]45(11): 118224
      How cells integrate nutrient availability to coordinate metabolism and growth remains poorly understood. Here, we identify branched-chain amino acid (BCAA) synthesis as a metabolic sensing system linking mitochondrial activity to translational and transcriptional control. Yeast limits Leu and Val import and instead relies on their synthesis, allowing BCAA production to reflect mitochondrial anabolic capacity. Reduced Val synthesis activates Gcn2, whereas reduced Leu synthesis inhibits TORC1, together decreasing translation efficiency and restricting growth. This response lowers levels of the transcriptional repressor Mig1, suppressing the Warburg/Crabtree effect and promoting alternative carbon source utilization. Remarkably, pharmacological inhibition of Leu/Val synthesis induces this metabolic reprogramming even in nutrient-rich medium, indicating that mitochondrial BCAA synthesis can partially override other nutrient-sensing pathways. Thus, BCAA synthesis couples mitochondrial anabolic capacity to Gcn2 and TORC1 activity and, through translational control of transcription factor abundance, shapes cellular metabolism.
    Keywords:  CP: metabolism; Gcn2; TORC1; Warburg effect; amino acid synthesis; diauxic shift; mitochondria; starvation
    DOI:  https://doi.org/10.1016/j.celrep.2026.118224
  10. EMBO Rep. 2026 Oct 28.
      The branched chain amino acids (BCAAs: leucine, isoleucine, valine) are essential amino acids that function as catabolic substrates and signaling molecules via mTORC1. While individual BCAAs have unique roles in organismal and cellular physiology, the mechanisms underlying their individual effects remain poorly understood. We demonstrate that the three BCAAs have distinct roles in T cell biology. We find that isoleucine and valine are necessary and sufficient for quiescence exit and cell division, whereas leucine is dispensable. Mechanistically, these effects are independent of their diverging catabolic fates and instead due to differential sensing of leucine and isoleucine/valine by mTOR and c-Myc. While isoleucine and valine are necessary and sufficient for c-Myc expression, mTORC1 leucine-sensing represses c-Myc and proliferation during BCAA restriction. Together, we find that the discrete sensing of the BCAAs uncouples two major anabolic regulators, mTORC1 and c-Myc, in cell growth. This provides mechanistic insight into the distinct roles of the BCAAs in cell physiology, highlighting divergent BCAA sensing rather than catabolism, and offering a new lens to appreciate their impact on immunity and pathophysiology.
    DOI:  https://doi.org/10.1038/s44319-026-00919-w
  11. J Cell Sci. 2026 Nov 01. pii: jcs264943. [Epub ahead of print]139(21):
      Spatial chromatin organization dictates cellular function and resilience, yet scalable imaging methods to quantify chromatin states in situ across aging and interventions are lacking. Although ATAC-see can visualize accessible chromatin, its broader application is hindered by protocol variability, low throughput and incompatibility with complex tissues. Here, we systematically optimize the ATAC-see workflow for robust, high-throughput quantitative imaging in fixed, adherent mammalian cells and fresh frozen tissues. We validate the sensitivity of the platform to pharmacologic remodeling and apply it to replicative, chronological and pathological aging in primary human fibroblasts, revealing progressive age-associated chromatin opening and heterochromatin remodeling. Furthermore, we demonstrate that our optimized ATAC-see captures rapid, reversible chromatin reorganization during OSK(M)-driven partial reprogramming of aged fibroblasts. Finally, we extend a cost-effective and accessible protocol to murine tissue sections, quantifying in situ age-dependent remodeling. This standardized framework establishes chromatin accessibility as a highly scalable, sequencing-compatible imaging biomarker for evaluating aging and rejuvenation.
    Keywords:  ATAC; ATAC-see; Aging; Cellular reprogramming; Chromatin accessibility; Epigenetics
    DOI:  https://doi.org/10.1242/jcs.264943
  12. Cell. 2026 Oct 29. pii: S0092-8674(26)01140-2. [Epub ahead of print]189(22): 6902-6903
      In this issue of Cell, Grońska-Pęski et al. examine how calorie restriction (CR) affects DNA mutation rates. While CR lowers the accumulation of mutations, this effect does not scale with the degree of lifespan extension. Their work raises important new questions about how CR impacts the causal mechanisms of aging.
    DOI:  https://doi.org/10.1016/j.cell.2026.09.038
  13. bioRxiv. 2026 Oct 07. pii: 2026.10.06.757085. [Epub ahead of print]
      Supratentorial ependymomas (ST-EPNs) are aggressive pediatric brain tumors predominantly driven by the recurrent ZFTA-RELA fusion, an oncogenic chromatin regulator that establishes an aberrant transcriptional program. Although metabolic pathways modulate epigenetic regulation by controlling the availability of metabolic cofactors, how ZFTA-RELA coordinates metabolic reprogramming with epigenetic regulation is not well understood. Here, we show that ZFTA-RELA-positive ependymomas exhibit enhanced methionine dependency, elevated adenosyl homocysteinase (AHCY) expression, and epigenetically control aspartate metabolism for tumor growth. Mechanistically, ZFTA-RELA upregulates AHCY, increasing cellular methylation potential which promotes H3K4me3-dependent expression of CAD, the first enzyme complex of de novo pyrimidine biosynthesis, while simultaneously enforcing H3K27me3 mediated repression of ASNS, which encodes asparagine synthetase. Through this coordinated epigenetic program, aspartate utilization is directed toward pyrimidine biosynthesis while endogenous asparagine production is limited. Restricting S-adenosylmethionine availability or genetically or pharmacologically inhibiting AHCY reverses these epigenetic states, leading to CAD downregulation, ASNS upregulation, impaired nucleotide synthesis, and suppression of tumor growth in vitro and in vivo. Similarly, EZH2 inhibition also restores ASNS expression and suppresses tumor proliferation. These findings suggest that ZFTA-RELA EPN maintain ASNS-low phenotype which conditionally make them dependent on extracellular asparagine. We further show that enhanced de novo pyrimidine synthesis not only supports nucleotide production but also provides UDP-sugars required for N-glycosylation and stabilization of the asparagine transporter SLC1A5, thereby promoting extracellular asparagine uptake and tumor proliferation. Collectively, our findings identify AHCY as a critical metabolic regulator of epigenetic and metabolic reprogramming that drives pyrimidine synthesis and establishes extracellular asparagine dependency, revealing actionable metabolic vulnerabilities in ZFTA-RELA-positive ST-EPNs.
    Abstract Figure:
    Key Findings: ZFTA-RELA fusion drives aspartate metabolic reprogramming through chromatin regulationAdenosylhomocysteinase (AHCY) epigenetically enhance de novo pyrimidine synthesis and suppress endogenous asparagine synthesis ZFTA-RELA EPNs exhibit ASNS low phenotype and dependence on extracellular asparagine Enhanced de novo pyrimidine biosynthesis fuels nucleotide synthesis and SLC1A5-dependent asparagine uptakeTargeting de novo pyrimidine biosynthesis and depleting extracellular asparagine reveal actionable vulnerabilities in ZFTA-RELA ST-EPN.
    DOI:  https://doi.org/10.64898/2026.10.06.757085
  14. bioRxiv. 2026 Sep 03. pii: 2026.09.01.748636. [Epub ahead of print]
    Somatic Mosaicism across Human Tissues Network
      Although all cells in the body descend from one genome, they accumulate distinct genetic and epigenetic changes over a lifetime, producing a mosaic of somatic variation that can shape development, aging, and disease. This mosaicism is often studied in isolation, leaving unclear how these forms relate within and between individuals. Here, we present the first integrated analysis of the Somatic Mosaicism across Human Tissues (SMaHT) Network's production resource, profiling up to 20 tissues from 25 donors using short- and long-read, duplex, single-cell, transcriptomic, and epigenomic sequencing, alongside donor-specific near-telomere-to-telomere assemblies. Somatic mutation burden cannot be captured by a single data type or metric, as tissues accumulate distinct variant classes largely independently of one another. Long-read and single-cell data resolved cell-type-specific mutational processes, traced mobile element insertions to source loci, and revealed the developmental timing and functional consequences of individual mutations. Donor-specific assemblies uncovered elevated mutation rates within centromeres and segmental duplications inaccessible to standard reference genomes, while haplotype-resolved chromatin and methylation data showed that nongenetically-deterministic epigenetic states are pervasive across tissues. Together, these findings provide an integrated, multi-scale portrait of somatic mosaicism across the human body, establishing a baseline against which its contributions to aging and disease can be measured.
    DOI:  https://doi.org/10.64898/2026.09.01.748636
  15. Trends Cancer. 2026 Oct 30. pii: S2405-8033(26)00239-6. [Epub ahead of print]
      Advancements in in vivo stable isotope tracing have revolutionized our understanding of cancer metabolism, transitioning the field from static metabolomic snapshots to dynamic metabolic pathway activities. However, interpreting raw fractional enrichment data presents significant biological and analytical challenges. This review systematically examines the methodological landscape of in vivo tracing, addressing the interpretive gap created by clinical constraints, such as single-timepoint surgical sampling. We dissect how secondary circulating tracers and the inherent heterogeneity of the tumor microenvironment can confound metabolic signals. We highlight the critical transition to metabolic flux analysis as the requisite computational step to overcome these challenges and to identify targetable metabolic vulnerabilities in precision oncology.
    Keywords:  digital twins; in vivo isotope tracing; isotope tracing in patients; metabolic flux analysis; tumor heterogeneity; tumor metabolism
    DOI:  https://doi.org/10.1016/j.trecan.2026.10.005
  16. Res Sq. 2026 Sep 03. pii: rs.3.rs-10756850. [Epub ahead of print]
       Background: Aging in the immune system results in increased susceptibility to infections, exacerbated autoimmunity, and reduced responsiveness to vaccines. However, there are no current established interventions for immune aging. Ketogenic diets and fasting have been researched as interventions against other aspects of aging and age-related diseases, and they work in part by increasing circulating levels of ketone bodies, which have anti-inflammatory properties and can boost T cell function. Exogenous ketones, such as ketone esters, are currently being studied as a more accessible approach to obtain the benefits of ketone bodies through direct supplementation. Here, we investigated whether ketone ester supplementation improves immune function during aging. Aged (19-month-old) C57BL/6JN mice were given a diet supplemented with the ketone ester or a control diet for 15 weeks.
    Results: We found that the ketone ester diet decreased activation of B cells, especially age-associated B cells, in the spleen. The diet also reduced the proportion of age-associated B cells defined by CD11b and CD11c expression, though not of the broader CD21-CD23- population. Despite this decrease in activation, there was no impairment in antibody production, as mice on the ketone ester diet mounted a normal response to nitrophenyl-ovalbumin immunization. The ketone ester diet also reduced glucose dependence and translation in subsets of age-associated B cells. Treating splenocytes from aged mice with β-hydroxybutyrate was sufficient to suppress B cell translation and reduced mTORC1 signaling, indicating that ketone bodies act directly on B cells. β-hydroxybutyrate also decreased expression of T-bet, the signature transcription factor driving the autoimmune functions of age-associated B cells.
    Conclusions: Our study elucidates the effect of ketone esters on B cells in the context of aging and unveils a new immunoregulatory role of ketone bodies on B cells.
    Keywords:  B cell activation; Ketone ester; T-bet; age-associated B cells; immune aging; translation; β-hydroxybutyrate
    DOI:  https://doi.org/10.21203/rs.3.rs-10756850/v1
  17. bioRxiv. 2026 Oct 09. pii: 2026.10.08.757705. [Epub ahead of print]
      Mitochondrial DNA (mtDNA) mutations cause inherited disease, accumulate with age, and recur in tumors, yet their effects remain unresolved because existing models interrogate one engineered allele at a time. We developed mtDIVE, a random C→T mutagenesis platform for pooled mitochondrial forward genetics in human epithelial cells and zebrafish embryos. mtDIVE generates genotypes ranging from single substitutions to >100 mutations per molecule, impairs respiration, and causes lineage-specific developmental delay. Coupling single-cell transcriptomics with mtDNA genotyping revealed that selection on mutant genomes and their transcriptional consequences depend on metabolic state and developmental lineage. Obligate OXPHOS eliminates highly mutated cells by apoptosis, whereas glycolytic conditions promote their competitive displacement. Individual loci exert modest but non-redundant effects that predict cell state beyond aggregate mutation burden, and cancer-recurrent variants are enriched among mutations linked to reduced mitochondrial transcription. Thus, mtDIVE links mtDNA genotypes to cellular phenotypes, separating the consequences of mutation identity from mutational load.
    DOI:  https://doi.org/10.64898/2026.10.08.757705
  18. bioRxiv. 2026 Oct 09. pii: 2026.10.08.757616. [Epub ahead of print]
      Cancer cachexia causes pathological weight loss, anorexia, and depressive symptoms, culminating in increased mortality. Using mouse models of pancreatic cancer cachexia, we identify tumor and hepatic inflammatory signaling, multi-organ energy charge depletion, and altered tryptophan metabolism. Metabolomic profiling and stable isotope tracing revealed altered tryptophan fates: serotonin depletion and kynurenine accumulation across tumor, liver, muscle and spleen. Kynurenine accumulation involved accelerated conversion of tryptophan to kynurenine with slowed downstream conversion to kynurenic acid. Restoring serotonin activity pharmacologically or metabolically normalized feeding, locomotion, and depression-like behavior, but wasting, tumor burden, and survival remained unchanged. Blocking kynurenine production or kynurenine-mediated AhR activation pharmacologically produced similar results. Thus, in cancer cachexia, the tryptophan pathway is subverted to deplete serotonin and accumulate kynurenine. This subversion contributes to cachexia-associated behavioral and feeding defects but not lethal systemic catabolism.
    Highlights: Tumors divert tryptophan from serotonin toward kynurenine accumulation in cachexiaSerotonin depletion contributes to behavioral alterations in cancer cachexiaKynurenine accumulation reduces feeding and activity via aryl hydrocarbon receptorCombined pathway targeting preserves fat mass but wasting remains unaltered.
    DOI:  https://doi.org/10.64898/2026.10.08.757616
  19. Cell Rep. 2026 Oct 30. pii: S2211-1247(26)01222-2. [Epub ahead of print]45(11): 118143
      Surviving despite accumulating toxic metabolites inside the cell is a defining feature of cancer evolution. In the current issue of Cell Reports, Eric Cheung and coworkers identify a mechanism that enables the survival of malignant pancreatic ductal adenocarcinoma (PDAC) cells through the sequestration of reactive iron.1.
    DOI:  https://doi.org/10.1016/j.celrep.2026.118143
  20. Nat Chem Biol. 2026 Oct 28.
      Excessive nicotinamide adenine dinucleotide (NAD+) consumption fuels neurological pathogenesis, yet the limited benefit of NAD+ supplementation hints at unresolved toxicity from its catabolism. Here, we identify ADP-ribose, a neglected NAD+ catabolite generated by poly(ADP-ribose) polymerase 1 (PARP1) and poly(ADP-ribose) glycohydrolase, as an inducer of neuronal ferroptosis through nucleotide metabolic rewiring. We discovered that extracellular ADP-ribose directly binds and inhibits the nucleoside transporter equilibrative nucleoside transporter 2 (ENT2; SLC29A2), suppressing nucleotide salvage and driving compensatory hyperactivation of de novo purine and pyrimidine biosynthesis. This metabolic rerouting engages xanthine oxidase (XO) and dihydroorotate dehydrogenase (DHODH) to unleash superoxide bursts, triggering lipid peroxidation and ferroptotic neuronal death. ADP-ribose accumulates across neurological disease models and its acute administration recapitulates ferroptotic neurodegeneration in vivo. Targeting ADP-ribose signaling through PARP1 knockdown, NUDT9-mediated hydrolysis or dual XO/DHODH inhibition rescues delayed cognitive deficits in intracerebral hemorrhage models. These findings define the ADP-ribose-ENT2 axis as a metabolic driver of neuronal ferroptosis and reveal a druggable vulnerability in disorders marked by NAD+ hyperconsumption.
    DOI:  https://doi.org/10.1038/s41589-026-02355-2
  21. bioRxiv. 2026 Oct 11. pii: 2026.10.05.756890. [Epub ahead of print]
      SARM1 is an inducible NADase that executes pathological axon degeneration, but how NAD+ destruction causes neuronal failure remains unclear. Because SARM1 is predicted to act outside the mitochondrial matrix, cytosolic NAD+ loss has been viewed as the critical lethal lesion. We show that SARM1 activation rapidly depletes cytosolic and mitochondrial NAD+ and collapses ATP in both compartments, revealing early, coupled metabolic failure. Enhancing mitochondrial NAD+ import through SLC25A51, the mitochondrial NAD+ transporter, preserves mitochondrial NAD+, maintains mitochondrial function, and delays axon degeneration and neuronal death despite ongoing SARM1 activity. Unexpectedly, SLC25A51 restores cytosolic NAD+-dependent metabolism, reversing a glycolytic block and increasing NAD+ synthesis during stress. Glycolytic inhibition attenuates protection, identifying cytosolic metabolic recovery as an important component of neuronal resilience. AAV-SLC25A51 improves function in a chronic SARM1-dependent neuropathy model. Thus, mitochondrial NAD+ import gates SARM1-driven degeneration by limiting coupled mitochondrial-cytosolic metabolic failure, presenting a downstream intervention point for axon preservation.
    DOI:  https://doi.org/10.64898/2026.10.05.756890
  22. Cell Metab. 2026 Oct 28. pii: S1550-4131(26)00439-0. [Epub ahead of print]
      Chimeric antigen receptor (CAR) T cell therapy has revolutionized treatment of hematological malignancies, but cytokine release syndrome (CRS) remains a major toxicity. Fever-a hallmark of CRS-has been understudied as a modifier of therapeutic efficacy. In a retrospective cohort of patients with B cell acute lymphoblastic leukemia treated with CD22-directed CAR T cells (NCT02315612), sustained high-grade fever inversely correlated with clinical response. Mechanistically, experimental hyperthermia impaired proximal CAR signaling, reduced cytotoxicity, and compromised metabolic fitness through dysregulated arginine metabolism. Arginine supplementation restored CAR T cell function following hyperthermic stress and enhanced cytotoxicity under normothermic conditions. This effect required mTOR-dependent recruitment of the eIF4F translation-initiation complex and downstream c-MYC-driven metabolic reprogramming. Importantly, arginine enhanced good manufacturing practice (GMP)-manufactured CAR T cell function under normothermia, while oral supplementation improved in vivo efficacy. These findings identify metabolic control of translation as a fever-sensitive checkpoint and establish arginine supplementation as a tractable strategy to enhance CAR T cell efficacy.
    Keywords:  CD22; arginine; c-MYC; chimeric antigen receptor T cell therapy; cytokine release syndrome; fever; mTOR; metabolic fitness; mitochondrial function; translation initiation
    DOI:  https://doi.org/10.1016/j.cmet.2026.10.001
  23. Am J Physiol Cell Physiol. 2026 Oct 24.
      Sestrin1, 2, and 3 are a family of stress-response proteins implicated in the pathogenesis of many diseases. Sestrins effect on AMP-activated kinase (AMPK) and mechanistic target of rapamycin (mTOR) affecting bioenergetics is most studied; however, how Sestrins directly affect metabolism is poorly understood. Wildtype (WT) HEK293T kidney cells were transfected with plasmids expressing individual FLAG-tagged Sestrins. FLAG-tagged Sestrins were immunoprecipitated and found to interact with Phosphofructokinase, a rate-limiting glycolytic enzyme, in a glucose-dependent manner. WT and Sestrin triple knockout (TKO) HEK293T cells were then subjected to glycolytic and mitochondrial stress tests and analyzed for metabolic flux via Seahorse analysis. TKO cells demonstrated higher glycolytic flux, higher ATP production but similar mitochondrial flux, and reduced proliferation compared to WT cells. Thereafter, WT and TKO cells were glucose-deprived or glucose-deprived followed by glucose addback and then characterized by steady-state metabolomics. TKO cells possessed elevations in glycolytic metabolites with glucose addback compared to WT cells. Similarly, WT and TKO cells were deprived of glucose followed by stable isotope tracing with [13C]glucose. TKO cells possessed higher abundances of glycolytic metabolites as well as elevated extracellular lactate. This effect resembles the Warburg effect; thus, WT and TKO primary tumor cells were tested for metabolic flux via Seahorse analysis to test the importance of Sestrins in cancer metabolism. TKO primary tumor cells demonstrated elevated glycolytic flux compared to WT. These data support a model wherein Sestrins are necessary to maintain metabolic flux homeostasis through a previously unknown regulatory mechanism involving interaction between Sestrins and metabolic enzymes.
    Keywords:  Metabolic flux; cancer; nutrient signaling; rate-limiting enzyme; stable isotope tracing
    DOI:  https://doi.org/10.1152/ajpcell.90221.2026
  24. Nat Cancer. 2026 Oct 29.
      Despite decades of investigation, the fundamental molecular and cellular principles that enable bacteria to thrive within the tumor microenvironment have yet to be defined. Here, through a genome‑wide functional screen, we identify the bacterial genes and pathways that govern intratumoral fitness. Targeted deletion of nonglucose phosphotransferase systems to align bacterial metabolic preference with tumor metabolite availability promotes bacterial intratumoral fitness. Integrating multiple metabolic adaptations into a single tumor‑avid Escherichia coli strain (Ec‑TA) results in increased tumor colonization, not only after intratumoral delivery but also after intravenous delivery, leading to increased anti‑tumor efficacy when using Ec‑TA engineered to deliver an encoded immunostimulatory payload. Furthermore, Ec‑TA displaces wild‑type bacteria from pre‑colonized tumors when administered systemically, underscoring its potential for locally delivering therapeutics in the presence of resident tumor microbes. These data demonstrate that adapting bacteria to the unique characteristics of the tumor metabolic microenvironment can drive the development of safer and more effective chassis for next‑generation bacterial cancer therapies.
    DOI:  https://doi.org/10.1038/s43018-026-01263-7
  25. Cell Rep. 2026 Oct 29. pii: S2211-1247(26)01073-9. [Epub ahead of print]45(11): 117995
      Mitochondrial DNA (mtDNA) depletion and multiple deletions frequently coexist in mitochondrial disease, neurodegeneration, and aging, yet how the two relate and why deletions accumulate focally remain unresolved. Here, longitudinal bulk and in situ analyses of Mpv17-/- murine muscle reveal that a compensatory rise in mitochondrial transcripts per mtDNA initially offsets severe, uniform mtDNA depletion, preserving the respiratory chain. However, this response carries a delayed cost: by six months transcripts decline, mtDNA deletions emerge, and respiratory-deficient fibers appear. Paradoxically, fibers harboring deletions accumulate supra-physiological amounts of mtDNA, despite prior depletion. This expansion is invariably accompanied by elevated Hsp60, and the same holds in human mitochondrial myopathy. We propose that depletion reprograms mitochondrial DNA and RNA metabolism, inadvertently promoting deletion formation and creating an Hsp60-high fiber state permissive for clonal expansion. Therefore, depletion and multiple deletions can be sequential phases of a common degenerative process, relevant also to aging and neurodegeneration.
    Keywords:  CP: molecular biology; Hsp60; clonal expansion; mTORC1; mitochondrial DNA; mitochondrial DNA deletions; mitochondrial DNA depletion; mitochondrial myopathy; nanopore sequencing of mitochondrial DNA; single-fiber analysis; stress response
    DOI:  https://doi.org/10.1016/j.celrep.2026.117995
  26. Mol Cancer Ther. 2026 Oct 29.
      Pancreatic ductal adenocarcinoma (PDAC) displays profound metabolic plasticity that sustains rapid proliferation through heightened demands for nucleotide biosynthesis. Here, we characterize HOSU-53 (JBZ-001), a dihydroorotate dehydrogenase (DHODH) inhibitor demonstrating potent antitumor activity in preclinical PDAC models and define the metabolic determinants of sensitivity and resistance. In HOSU-53-sensitive PDAC cells, DHODH inhibition induces G₂/M cell cycle arrest and triggers apoptotic and ferroptotic cell death. In contrast, resistant cells evade metabolic stress by activating compensatory nucleoside transport and macropinocytosis pathways. Integrated functional and genetic analyses reveal that nucleoside salvage via the equilibrative nucleoside transporter SLC29A1 constitutes a dominant resistance mechanism, enabling uptake of extracellular nucleosides to bypass de novo pyrimidine synthesis. Unbiased metabolomic profiling demonstrates that combined inhibition of DHODH and SLC29A1 precipitates mitochondrial dysfunction, oxidative stress, lipid remodeling, and amino acid depletion, culminating in metabolic collapse and energetic failure. Consistent with these findings, dual inhibition markedly suppresses tumor growth and metastatic burden in xenograft and syngeneic orthotopic PDAC models while reprogramming the tumor microenvironment toward a pro inflammatory, immune activated state. Furthermore, co targeting DHODH and SLC29A1 synergizes with anti-PD 1 immune checkpoint blockade, enhancing immunotherapeutic efficacy. Together, these results establish dual targeting of de novo and salvage nucleotide metabolism as a compelling strategy to overcome metabolic resistance, remodel tumor-immune interactions and potentiate therapeutic responses in PDAC.
    DOI:  https://doi.org/10.1158/1535-7163.MCT-26-0461
  27. J Cell Sci. 2026 Oct 15. pii: jcs264886. [Epub ahead of print]139(20):
      GCN2 (also known as EIF2AK4) is a conserved serine/threonine kinase best known for linking amino acid availability to activation of the integrated stress response (ISR) through phosphorylation of eukaryotic translation initiation factor 2α (eIF2α). This canonical activity promotes adaptive translational and transcriptional programmes that support metabolic homeostasis and stress tolerance, which has motivated efforts to therapeutically target GCN2, particularly in cancer. Recent work, however, indicates that this framework captures only a subset of GCN2 biology. GCN2 has been shown to engage additional substrates beyond eIF2α, including the methionyl-tRNA synthetase (MARS1) and the catalytic subunits of protein phosphatase-1 (PP1), and has been implicated in a growing range of cellular processes, such as mitotic fidelity, cell migration and ribosome homeostasis. Together, these findings establish GCN2 as a multifunctional kinase whose cellular roles cannot be inferred solely from canonical ISR readouts. Here, we synthesize emerging evidence for noncanonical GCN2 activities and consider how this expanded view shapes interpretation of genetic and pharmacological perturbations and the development of therapeutic strategies targeting GCN2.
    Keywords:  GCN2; ISR; Migration; Mitosis; Non-canonical; Ribosome homeostasis
    DOI:  https://doi.org/10.1242/jcs.264886
  28. bioRxiv. 2026 Oct 09. pii: 2026.10.08.757672. [Epub ahead of print]
      Cancer cachexia is a debilitating wasting syndrome associated with involuntary weight loss, reduced appetite and food intake, adipose and muscle atrophy, and systemic inflammation with induction of a myriad of candidate cachexia factors. Using a multi-omic approach in a genetically engineered mouse model of lung cancer cachexia, we found that early circulating metabolic alterations preceded overt weight loss. Although both cachexia and fasting are characterized by a reduction in food intake, we show that the systemic metabolic changes in cachexia are distinct, indicating a lack of induction in the normal protective response to negative energy balance during cachexia. Cancer cachexia causes profound hepatic reprogramming, and activation of inflammatory programs, alongside muscle atrophy and elevation of circulating cytokines. However, targeting individual candidate cachectic factors such as IL-6, TNF-α, GDF15, CCL2, LIF, and IL17A failed to rescue weight loss or prolong survival. In contrast, caloric restriction initiated prior to tumor induction elicited a program of protection during tumor progression that attenuated multi-tissue inflammatory and catabolic transcriptional responses, preserved lean mass, and prolonged survival. Together, these findings suggest that metabolic preconditioning broadly dampens systemic inflammation and delays the onset and progression of cancer cachexia.
    HIGHLIGHTS: Despite both fasting and cachexia involve reduced nutrient intake, the metabolic alterations are distinct.Cachexia induces a systemic inflammatory response.Single targeting of implicated cachectic factors fails to rescue weight loss or survival in cancer cachexia.Caloric restriction pre-conditioning to enforce the protective response to nutrient limitation attenuates cachexia.
    DOI:  https://doi.org/10.64898/2026.10.08.757672
  29. Cancer Res. 2026 Oct 27.
      Metabolic reprogramming is a well-described hallmark of clear cell renal cell carcinoma (ccRCC). Gene copy number variation and altered gene expression data suggest enhanced branched-chain amino acid (BCAA) transamination and reduced BCAA oxidation are highly selected traits in ccRCC. Surprisingly, we found that genetic modulation of BCAA oxidation had little effect on experimental ccRCC cell growth in vitro and in vivo. In contrast, BCAA transamination in ccRCC cells was essential for the generation of glutamate-derived glutathione and cell viability when glutamine was limiting. Thus, BCAA transamination conferred resistance to states of low glutamine or treatment with the glutaminase inhibitor CB-839 by providing glutathione independent of glutamine breakdown. Targeting BCAA transamination in vitro and in vivo sensitized ccRCC to CB-839 mediated glutaminase inhibition by decreasing glutathione biosynthesis and redox homeostasis. These findings reveal that BCAA transamination maintains critical glutamate and glutathione levels in glutamine-deprived ccRCC, explaining why CB-839 treatment has been ineffective in ccRCC clinical trials and demonstrate an approach to treat ccRCC by targeting BCAA transamination to create a vulnerability to glutaminase inhibition.
    DOI:  https://doi.org/10.1158/0008-5472.CAN-26-0563
  30. Science. 2026 Oct 29. 394(6823): eaed2525
      Targeted protein degradation is a promising modality to treat cancer or inflammation, but whether it can provide a similar benefit for disorders caused by pervasive protein dysregulation is unclear. We describe stimulated protein degradation (SPD) as a strategy that leverages agonists of stress-responsive E3 ubiquitin ligases to simultaneously eliminate multiple pathogenic factors. Specifically, we show that activators of the reductive stress response E3 CUL2FEM1B boost degradation of multiple physiological substrates to improve mitochondrial import and electron transport chain assembly. In this manner, CUL2FEM1B agonists preserve mitochondrial function and neuronal survival in models of neurodegenerative COX deficiency syndrome and Friedreich's ataxia. By activating E3 ligases that evolved to safeguard cellular integrity, SPD expands the use of compound-induced protein degradation to complex pathologies of high unmet need.
    DOI:  https://doi.org/10.1126/science.aed2525
  31. Nucleic Acids Res. 2026 Oct 24. pii: gkag976. [Epub ahead of print]54(20):
      DNA repair defects such as nucleotide excision repair (NER) mutations can lead to progeroid syndromes characterized by growth retardation and accelerated aging with distinct tissue type specific pathologies. DNA-damage-induced dysfunction of specific cell types can impair the organism's overall function. It is unknown whether, in reverse, DNA repair in specific tissues can have non-cell-autonomous consequences on other tissues carrying DNA damage. To explore the organismal consequences of cell-type-specific DNA repair, we restricted NER activity to specific tissues and monitored consequences on organismal health in Caenorhabditis elegans. Unexpectedly, we observed that tissue-specific DNA repair is sufficient to improve overall DNA damage resistance. Strikingly, NER activity restricted to neurons only is sufficient to provide similar overall DNA damage resistance as whole-body NER in almost all tissues tested. We show that this systemic DNA damage resilience is mediated by neuronal acetylcholine signaling that promotes the maintenance of mitochondrial activity throughout the organism.
    DOI:  https://doi.org/10.1093/nar/gkag976
  32. bioRxiv. 2026 Sep 03. pii: 2026.09.02.748294. [Epub ahead of print]
      Genome-scale metabolic models can predict how individual cells allocate resources and respond to their environment, yet few frameworks link single-cell metabolism to the spatial organisation of multicellular systems. Here we introduce PhysiCelldFBA, an extension of the PhysiCell agent-based framework that couples genome-scale dynamic flux balance analysis to off-lattice multicellular simulations. Each simulated cell carries its own metabolic model, allowing local environmental conditions to shape metabolism while metabolic activity feeds back on the surrounding environment, cellular behaviour, and spatial organisation. We first validate this coupling by showing that glucose consumption, CO 2 production, and biomass accumulation remain mass-balanced in a closed E. coli system, with simulated biomass agreeing with analytical predictions to within 1%. We then demonstrate how metabolic phenotypes emerge from this coupling across microbial and mammalian systems. Spatial nutrient gradients generate metabolic stratification and acetate cross-feeding in growing E. coli colonies; diffusion-limited metabolism produces proliferative, hypoxic, and necrotic zones across a broad panel of metabolites in a tumour-like tissue; distinct, organism-specific metabolic networks give rise to syntrophic cross-feeding and spatial niche formation in a two-species consortium; and metabolic state couples energy availability to transitions between cellular motility and growth. Across these examples, metabolic stratification, cross-feeding, and phenotypic adaptation emerge from local metabolic optimisation and environmental feedback rather than being explicitly prescribed. PhysiCelldFBA therefore provides a general framework for simulating genome-scale metabolism at single-cell resolution and linking intracellular metabolic state to cellular behaviour and emergent organisation across scales.
    DOI:  https://doi.org/10.64898/2026.09.02.748294
  33. Nature. 2026 Oct 28.
      Dynamic interactions between tumours and their microenvironment are crucial for cancer progression and therapeutic outcomes1,2. However, our understanding of these relationships remains limited by the constrained capacity of current human model systems to manipulate diverse cellular components and to interrogate complex tumour-stroma crosstalk. Here we generated combinatorial, mix-and-match tumour assembloids by conditionally reconstituting multiple components of human renal cell carcinoma, including cancer cells, cancer-associated fibroblasts (CAFs) and tumour-infiltrating immune cells. Using genetically engineered renal cell carcinoma assembloids with humanized mouse models, we uncovered mechanisms by which CAFs coordinate interactions between tumour cells and CD8+ T cells to maintain non-cell-autonomous CD8+ T cell stemness and drive responsiveness to anti-PD-1 therapy. These interactions operate through a tumour-CAF-T cell signalling axis in which tumour-derived WNT induces CAF expression of activin A, which enhances CD8+ T cell stemness and sensitivity to PD-1 blockade. In non-responders, we also identified a subset of WNT-unresponsive CAFs that do not produce activin A, which leads to impaired CD8+ T cell stemness and resistance to therapy. Together, these findings establish a tumour-CAF-T cell axis as a key determinant of heterogeneous responses to immune checkpoint inhibitors. Moreover, tumour assembloids provide a versatile platform for mechanistic dissection of the tumour microenvironment and evaluation of personalized immunotherapy strategies.
    DOI:  https://doi.org/10.1038/s41586-026-11208-w
  34. Cell Rep. 2026 Oct 26. pii: S2211-1247(26)01280-5. [Epub ahead of print]45(11): 118201
      The RAS/RAF/MEK/ERK pathway has been extensively studied for its roles in physiology and disease, yet a systems-level view of its interplay with the broader cellular context is lacking, limiting insight into paralog-specific roles, mutation-driven rewiring, and cross-pathway integration. To address this, we simultaneously mapped the interactomes of all pathway components and their activating and inactivating mutations, identifying 2,500 high-confidence interactors, 88% of which previously unreported, and generating a high-confidence, comprehensive reference map of the pathway in resting and activated states. The pathway behaves like a "molecular organism" that connects to other signaling complexes, operates from distinct subcellular sites, and integrates into networks relevant to physiology and disease. Dataset exploration uncovers paralog- and mutation-specific interaction signatures and pathway-level crosstalk, including previously unknown connections to mRNA metabolism and WNT signaling. The interactomes available at RAStoERK.univie.ac.at provide a foundational community resource for unbiased discovery, targeted mechanistic studies, and potential therapeutic exploration.
    Keywords:  AP-MS; CP: molecular biology; RAS-RAF-MEK-ERK pathway; cancer signaling; interactome; network biology; oncogenic mutations; pathway crosstalk; protein-protein interactions; proteomics; proximity labeling
    DOI:  https://doi.org/10.1016/j.celrep.2026.118201
  35. Science. 2026 Oct 29. 394(6823): eaee5920
      At the skin's surface, the epidermis must balance stem cell renewal with barrier maintenance to withstand environmental stress and shield against pathogens. In this study, we identify a microbial-immune-epithelial feedback mechanism that integrates environmental information into stem cell regulation in mice. Specifically, we show that Langerhans cells (LCs), an intraepithelial macrophage population, orchestrate this circuit by producing prostaglandin E2, which restrains stem cell proliferation, promotes epidermal differentiation, and maintains barrier integrity during homeostasis. Upon pathway disruption, stem cells become overactivated, hindering terminal differentiation and weakening barrier function. Upstream, LC activity is tuned by the local microbial environment in a rheostat-like fashion, coupling commensal sensing to stem cell dynamics. Our findings provide a general framework for how barrier tissues achieve adaptive homeostasis amid continual external fluctuations.
    DOI:  https://doi.org/10.1126/science.aee5920
  36. Nat Rev Cancer. 2026 Oct 26.
      Single-cell genomics has entered the field of cancer research and clinical oncology, enhancing our understanding of the somatic evolution of cancer and intra-tumour genomic heterogeneity. The evolutionary history of a tumour can be represented as a phylogenetic tree, and in recent years, multiple statistical and computational methods have been proposed to reconstruct tumour phylogenies from single-cell sequencing data. The nature of tumour evolution and of single-cell sequencing, however, raises new challenges in modelling the data and the underlying evolutionary processes that are not addressed by classical phylogenetic and phylodynamic approaches. Here, we review the models and assumptions behind bespoke single-cell tumour phylogeny methods, along with recent computational and algorithmic advances in phylogenetic inference. We discuss the role these advances have in basic and clinical oncology research, and how they provide new insights into individual cancers and cohorts of patient samples. We conclude with an outlook of current challenges for single-cell phylogenetics and potential future applications.
    DOI:  https://doi.org/10.1038/s41568-026-00992-2
  37. Sci Adv. 2026 Oct 30. 12(44): eaeg0361
      Dietary restrictions are increasingly recognized as modulators of immune cell function. However, how they shape CD8+ T cell fate decisions remains incompletely understood. Here, we investigated the impact of intermittent fasting (IF) on differentiation of heterogeneous effector T cell subsets and the formation of a long-lived homeostatic memory pool. We found that IF skewed CD8+ T cell differentiation toward memory precursor effector cells (MPECs) and enhanced the central memory CD8+ T cell development and functions. Mechanistically, glucose restriction induced by IF promotes alternative metabolic fluxes leading to fatty acid oxidation. This metabolic shift enhanced mitochondrial fitness and supported MPEC differentiation via metabolic-epigenetic cross-talk, culminating in durable and functionally robust memory CD8+ T cell responses. Applying this strategy in adoptive transfer therapy, intratumoral defects could be circumvented by imprinting a memory phenotype under IF-mimicking conditions, resulting in improved and long-lasting antitumor activity. Collectively, these findings underscore the importance of IF in orchestrating metabolic-epigenetic cross-talk to enhance memory formation and antitumor immunity.
    DOI:  https://doi.org/10.1126/sciadv.aeg0361
  38. bioRxiv. 2026 Oct 07. pii: 2026.10.06.756889. [Epub ahead of print]
      Folate is an essential driver of one-carbon metabolism. The cellular consequences of its deprivation in CD8 + T cell and impact on anti-tumor function are unknown. Single cell RNA-seq analysis of primary central nervous system lymphoma (PCNSL) patients' tumor samples revealed exhaustion in T cells with high folate metabolism gene expression signature. Functional genomics, metabolite profiling, and glycomics identified disrupted cell surface glycosylation as a major consequence of folate deprivation in CD8 + T cells. Mechanistically, folate deprivation reduced nucleotide sugar levels, perturbed glycosylation, and triggered the apoptotic unfolded protein response. Overexpressing folate transporters in adoptively transferred CD8 + T cells increased intratumoral T cell numbers and reduced exhaustion. Therefore, our data draw a mechanistic line between one-carbon metabolism, cell-surface glycosylation, and anti-tumor T cell function, and support a hypothesis that increased folate uptake can enhance CD8 + T cell function including ex vivo and in vivo CAR-T cells.
    Highlights: Although folate metabolism genes are highly expressed in both proliferating tumor and CD8 + T cells from primary central nervous system lymphoma patients, the T cells are exhausted while the tumor cells thrive Folate is depleted in the TME of MC38-OVA and B16-OVA tumors Folate deprivation impairs function and proliferation of CD8 + T cells Folate is essential for nucleotide sugar metabolism, and its depletion results in perturbation of cell surface glycosylationGenetic engineering to increase folate uptake by T cells increases intratumoral T cell numbers and reduces exhaustion.
    DOI:  https://doi.org/10.64898/2026.10.06.756889
  39. J Cell Biol. 2026 Dec 07. pii: e202606052. [Epub ahead of print]225(12):
      Recent work from two independent studies has uncovered mitochondria as a previously unrecognized proton source driving lysosomal acidification. In this Viewpoint, we summarize these findings, examine the associated proteins and functional mechanisms, and discuss their relevance to disease.
    DOI:  https://doi.org/10.1083/jcb.202606052
  40. Clin Exp Immunol. 2026 Oct 27. pii: uxag066. [Epub ahead of print]
      Ageing is an important determinant of immune function across the lifespan, yet it remains underappreciated in the design and interpretation of much basic T cell research. As the immune system ages, T cell responses become less diverse, less efficient, and less adaptable, with consequences for infection control, vaccine responsiveness, cancer immunosurveillance, and the performance of T cell-based immunotherapies. This issue is particularly acute because many fundamental studies still rely on T cells from, mostly, healthy young donors. These controls are indispensable, but the field has built much of its pre-clinical logic on immune systems that are younger, fitter, and biologically distinct from the patients for whom T cell therapies are intended. We argue that this mismatch between experimental systems and clinical reality could be overcome by considering age as a routine variable from the start.
    Keywords:  T cell; ageing; metabolism
    DOI:  https://doi.org/10.1093/cei/uxag066